Highlights Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Market Closed - Nasdaq Copenhagen Other stock markets 08:29:56 08/05/2024 pm IST			5-day change	1st Jan Change
0.189 ^DKK	-19.23%		-23.17%	-56.05%

10/04	Pharma Equity Group A/S announced that it has received DKK 7.6 million in funding	CI
05/04	Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	05/04	CI
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
Pharma Equity Group A/S Provides Group Earnings Guidance for the Full Year 2024	20/03	CI
Pharma Equity Group's Subsidiary (Reponex Pharmaceuticals A/S) Receives Notification from the European Patent Office	22/01	CI
Pharma Equity Group A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/01	CI
Pharma Equity Group A/S Announces Positive Preliminary Results from the Phase-2 Clinical Trial	16/11	CI
Pharma Equity Group?S Subsidiary Company Reponex Pharmaceuticals A/S Receives Grant of Us Patent for A Method of Treatment on Its Topical Wound-Healing Composition	31/23/31	CI
Pharma Equity Group A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	16/23/16	CI
Reponex Pharmaceuticals Set for US Patent for Chronic Wound Treatment Method	15/23/15	MT
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10	CI
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10	CI
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Reponex Pharmaceuticals A/S completed the acquisition of Pharma Equity Group A/S.	24/23/24	CI
Bonus Issue: 1 new share for 1 existing share	27/23/27	FA
Blue Vision A/S Reports Earnings Results for the Half Year Ended June 30, 2022	31/22/31	CI
Blue Vision A/S (CPSE:BLVIS A) made an offer to acquire Reponex Pharmaceuticals A/S.	05/22/05	CI
Blue Vision A/S Reports Earnings Results for the Half Year Ended June 30, 2021	30/21/30	CI
Reverse Split: 1505 of 10000	01/19/01	FA
An outlandish company cancelled the acquisition of 79.3% stake in Portinho S.A. from Blue Vision A/S.	09/18/09	CI
H.C. Holding Investeringsaktieselskab A/S sold 9.01% stake in Blue Vision A/S.	13/17/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Highlights

Filters